Bristol-Myers Squibb Company (NYSE:BMY) to go ex-dividend.On 9/13/2017 Bristol-Myers Squibb Company ( NYSE:BMY ) announced that it will be issuing a quarterly dividend in the amount of $0.39 down from $0.39Bristol-Myers Squibb Company (NYSE:BMY) Ex- dividend dateBristol-Myers Squibb Company (NYSE:BMY) is set to go ex-dividend on and will be payable on 11/1/2017 Dividend History for Bristol-Myers Squibb Company (NYSE:BMY) The next payable dividend for Bristol-Myers Squibb Company is scheduled for 11/1/2017. There is an annual dividend of $$1.56 with a yield of 2.50% The company’s dividend has increased by 2.80% on a 3 Year Average The payout ration for the trailing 12 months of earnings is 56.73% , 52.35% based on this years estimates and 49.21% based on next years projected estimates.Recent Dividend History for Bristol-Myers Squibb Company (NYSE:BMY)
- On 12/4/2012 Bristol-Myers Squibb Company announced a quarterly dividend of $0.35.
- On 3/7/2013 Bristol-Myers Squibb Company announced a quarterly dividend of $0.35.
- On 6/19/2013 Bristol-Myers Squibb Company announced a quarterly dividend of $0.35.
- On 9/17/2013 Bristol-Myers Squibb Company announced a quarterly dividend of $0.35.
- On 12/19/2013 Bristol-Myers Squibb Company announced a quarterly dividend of $0.36.
- On 3/3/2014 Bristol-Myers Squibb Company announced a quarterly dividend of $0.36.
Recent Insider Trading for Bristol-Myers Squibb Company (NYSE:BMY)
- On 9/6/2017 Joseph C Caldarella, SVP, sold 9,340 with an average share price of $60.00 per share and the total transaction amounting to $560,400.00.
- On 8/2/2017 Theodore R Samuels II, Director, bought 6,000 with an average share price of $55.94 per share and the total transaction amounting to $335,640.00.
- On 4/7/2017 Lamberto Andreotti, Director, sold 34,000 with an average share price of $53.26 per share and the total transaction amounting to $1,810,840.00.
- On 3/28/2017 Lamberto Andreotti, Director, sold 34,000 with an average share price of $56.17 per share and the total transaction amounting to $1,909,780.00.
- On 3/27/2017 Lamberto Andreotti, Director, sold 17,000 with an average share price of $56.14 per share and the total transaction amounting to $954,380.00.
- On 3/17/2017 Louis S Schmukler, Insider, sold 5,000 with an average share price of $56.49 per share and the total transaction amounting to $282,450.00.
Recent Analyst Rating for Bristol-Myers Squibb Company (NYSE:BMY)
- On 9/12/2017 Hilliard Lyons, Downgrade, fromLong-term Buy to Neutral to Long-term Buy with a price target of $65.00
- On 9/11/2017 Jefferies Group LLC, Reiterated Rating, to bought with a price target of $66.00
- On 9/8/2017 Credit Suisse Group, Reiterated Rating, fromNeutral to Hold to Neutral
- On 9/7/2017 Goldman Sachs Group, Inc. (The), Reiterated Rating, to bought with a price target of $62.00 to $65.00
- On 9/4/2017 BMO Capital Markets, Reiterated Rating, to sold with a price target of $49.00
- On 8/14/2017 Cowen and Company, Set Price Target, to Hold with a price target of $65.00
Recent Trading for Bristol-Myers Squibb Company (NYSE:BMY) Shares of Bristol-Myers Squibb Company closed the previous trading session at with shares trading hands.